Surgically-treated early cervical cancer: Prognostic factors and the significance of depth of tumor invasion

International Journal of Gynecological Cancer

Volumn 9, Issue 3, 1999, Pages 212-219

  Hellebrekers, B W J ^a   Zwinderman, A H ^a   Kenter, G G ^a   Peters, A A W ^a   Snijders Keilholz, A ^a   Graziosi, G C M ^a   Fleuren, G J ^a   Trimbos, J B ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cervical carcinoma; Depth of invasion; Early cervical cancer; Local control; Lymph node metastasis; Prognostic factors; Radical hysterectomy

Indexed keywords

ARTICLE; BLEEDING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; EARLY DIAGNOSIS; FEMALE; HIGH RISK PATIENT; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OPERATION DURATION; PELVIS LYMPHADENECTOMY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; TUMOR VOLUME; UTERINE CERVIX CANCER;

EID: 0033041641     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1999.99023.x     Document Type: Article

References (37)

1. Sevin BU, Nadji M, Lampe B, Lu Y, Hilsenbeck S, Koechli OR, Averette HE. Prognostic factors of early stage cervical cancer treated by radical hysterectomy. Cancer 1995; 76(Suppl. 10): 1978-86.
2. Lee YN, Wang KL, Lin CH, Liu CH, Wang KG, Lan CC, Chuang JT, Chen AC, Wu CC. Radical hysterectomy with pelvic lymph node dissection for treatment of cervical cancer: A clinical review of 954 cases. Gynecol Oncol 1989; 35: 135-42.
3. Ayhan A, Tuncer ZS. Radical hysterectomy with lymph-adenectomy for treatment of early stage cervical cancer: Clinical experience with 278 cases. J Surg Oncol 1991; 47: 175-7.
4. Soisson AP, Soper JT, Pearson DLC, Berchuck A, Montana G, Greasman WT. Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer. Gynecol Oncol 1990; 37: 390-5.
5. Kinney WK, Alvarez RD, Reid GC, et al. Value of adjuvant whole-pelvis irradiation after Wertheim hysterectomy for early-stage squamous carcinoma of the cervix with pelvic nodal metastasis: A matched-control study. Gynecol Oncol 1989; 34: 258-62.
6. Morrow CP. Is pelvic radiation beneficial in the postoperative management of stage IB squamous cell carcinoma of the cervix with pelvic node metastasis treated by radical hysterectomy and pelvic lymphadenectomy? Gynecol Oncol 1980; 10: 105-10.
7. Burghardt E, Pickel H, Haas J, et al. Prognostic factors and operative treatment of stages IB to IIB cervical cancer. Am J Obstet Gynecol 1987; 156: 988-96.
8. Fuller AF, Elliott N, Kosloff C, Lewis JL. Lymph node metastases from carcinoma of the cervix, stage IB and IIA: Implications for prognosis and treatment. Gynecol Oncol 1982; 13: 165-74.
9. Kenter GG, Ansink AC, Heintz APM, Delemarre J, Aartsen EJ, Hart AAM. Low stage invasive carcinoma of the uterine cervix stage I-IIA: Morphological prognostic factors. Eur J Surg Oncol 1988; 14: 187-92.
10. Delgado G, Bundy BN, Fowler WC, Stehman FB, Sevin B, Creasman WT, Major F, Disaia P, Zaino R. A prospective surgical pathological study of stage I squamous carcinoma of the cervix. 1988. A Gynecologic Oncology Group Study. Gynecol Oncol 1989; 35: 314-20.
11. Delgado G, Bundy B, Zaino R, Sevin B, Creasman WT, Major FM. Prospective surgical-pathological study of disease-free interval in patients with squamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study. Gyncol Oncol 1990; 38: 352-7.
12. FIGO Cancer Committee. Staging announcement. Gynecol Oncol 1986; 25: 383-5.
13. Rutledge JH. Radical hysterectomy. In: Ridley JH, ed. Gynecol Surgery. Baltimore: Williams and Wilkins CO., 1974; 261-77.
14. Yagi H. Extended abdominal hysterectomy with pelvic lymphadenectomy for carcinoma of the cervix. The Okabayashi operation and its improved techniques. Am J Obstet Gynecol 1955; 69: 33-47.
15. Snijders-Keilholz A, Acht van M, Vroome de H, Hermans J, Trimbos JB, Leer JWH. Pelvic failure rate radiation toxicity in relation to total dose of radiation alone for the treatment of cancer of the uterine cervix. Clin Oncol 1993; 5: 6-10.
16. Cox DR. Regression model and life tables. J Roy Stat Soc 1972; 34 (Series B): 187-202.
17. Monaghan JM, Ireland D, Shlomo MY, Pearson SE, Lopes A, Sinha DP. Role of centralization of surgery in stage IB carcinoma of the cervix: A review in 498 cases. Gynecol Oncol 1990; 37: 206-9.
18. Burke TW, Hoskins WJ, Heller PB, Shen MC, Weiser EW, Park RC. Clinical patterns of tumor recurrence after radical hysterectomy in stage IB cervical carcinoma. Obstet Gynecol 1987; 69: 382-5.
19. Larson DM, Copeland LJ, Stringer CA, Gershenson DM, Malone JM, Creighton LE. Recurrent cervical carcinoma after radical hysterectomy. Gynecol Oncol 1988; 30: 381-7.
20. Kenter GG, Ansink AC, Heintz AP, Aartsen EJ, Delamarre JF, Hart AA. Carcinoma of the uterine cervix stage IB and IIA: Results of surgical treatment: Complications, recurrence and survival. Eur J Surg Oncol 1989; 15: 55-60.
21. Disaia PJ, Creasman WT. Clinical Gynecologic Oncology. St. Louis: The C.V. Mosby Company, 1989; 77.
22. Tinga DJ, Bouma J, Aalders JG. Patients with squamous cell versus adeno (squamous) carcinoma of the cervix, what factors determine the prognosis? Int J Gynecol Cancer 1992; 2: 83-91.
23. Webb MJ, Symmonds RE. Wertheim hysterectomy: A reappraisal. Obstet Gynecol 1979; 54: 140-5.
24. Benedet JL, Turko M, Boyes DA, Nickerson KG, Bienkowska BT. Radical hysterectomy in the treatment of cervical cancer. Am J Obstet Gynecol 1980; 137: 254-60.
25. Hoskins WJ, Ford JH, Lutz MH. Radical hysterectomy and pelvic lymphadenectomy for the management of early invasive cancer of the cervix. Gynecol Oncol 1976; 4: 278-90.
26. Samlal RAK, Velden JVD, Ketting BW, Gonzalez Gonzalez D, Ten Kate FJW, Harts AAM, Lammes FB. Disease-free interval and recurrence pattern after the Okabayashi variant of Wertheim's radical hysterectomy for stage IB and IIA cervical carcinoma, Int J Gynecol Cancer 1996; 6: 120-7.
27. Sall S, Pineda AA, Calanog A, Heller P, Greenberg H. Surgical treatment of stages IB and IIA invasive carcinoma of the cervix by radical abdominal hysterectomy. Am J Obstet Gynecol 1979; 135: 442-6.
28. Averette HE, Nguyen HN, Donato DM, Penalver MA, Sevin BU, Estape R, Little WA. Radical hysterectomy for invasive cervical cancer. Cancer 1993; 71(Suppl. 4): 1422-37.
29. Morley GW, Seski JC. Radical pelvic surgery versus radiation therapy for stage I carcinoma of the cervix (exclusive of microinvasion). Am J Obstet Gynecol 1976; 126: 785-94.
30. Langley II, Moore DW, Tarnasky JW, Roberts PHR. Radical hysterectomy and pelvic lymph node dissection. Gynecol Oncol 1980; 9: 37-42.
31. Mann WJ, Orr JW, Shingleton HM, Austin JM, Hatch KD, Taylor PT, Partridge E, Soong SJ. Perioperative influences on infectious morbidity in radical hysterectomy. Gynecol Oncol 1981; 11: 207-12.
32. Piver MS, Chung WS. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma. Obstet Gynecol 1975; 46: 507-10.
33. Chung CK, Nahhas WA, Stryker JA. Analysis of factors contributing to treatment failures in stages IB and IIA carcinoma of the cervix. Am J Obstet Gynecol 1980; 138: 550-6.
34. Fuller AF Jr, Elliott N, Kosloff C, Hoskins WJ, Lewis JL. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix. Gynecol Oncol 1989; 33: 34-9.
35. Greer BE, Figge DC, Tamimi HK, Cain JM. Stage IB adenocarcinoma of the cervix treated by radical hysterectomy and pelvic lymph node dissection. Am J Obstet Gynecol 1989; 160: 1509-14.
36. Logue JP, Hale RJ, Wilcox FL, Hunter RD, Buckley CH, Tindall VR. Carcinoma of the cervix: An analysis of prognostic factors, treatment and patterns of failure following Wertheims hysterectomy, Int J Gynecol Cancer 1992; 2: 323-7.
37. Monk BJ, Cha DS, Walker JL, Burger RA, Ramsinghani NS, Manetta A, PJ DiSaia, Berman ML. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma. Gynecol Oncol 1994; 54: 4-9.